Alcohol
Volume 21, Issue 3 , Pages 223-229 , July 2000

Alterations of IGF-binding proteins in patients with alcoholic liver cirrhosis

  • Olgica Nedić

      Affiliations

    • INEP — Institute for the Application of Nuclear Energy, Banatska 31b, 11080 Zemun, Yugoslavia
    • Corresponding Author InformationCorresponding author. Tel.: +38111-617-252; fax: +38111-618-724
    • ,
  • J.Anna Nikolić

      Affiliations

    • INEP — Institute for the Application of Nuclear Energy, Banatska 31b, 11080 Zemun, Yugoslavia
    • ,
  • Ljiljana Hajduković-Dragojlović

      Affiliations

    • Institute for Medical Research, Doktora Subotića 4, Belgrade, Yugoslavia
    • ,
  • Vera Todorović

      Affiliations

    • INEP — Institute for the Application of Nuclear Energy, Banatska 31b, 11080 Zemun, Yugoslavia
    • ,
  • Romana Masnikosa

      Affiliations

    • INEP — Institute for the Application of Nuclear Energy, Banatska 31b, 11080 Zemun, Yugoslavia

Received 10 April 1999 ,Revised 26 January 2000 ,Accepted 16 March 2000.

References 

  1. Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. J Hepatol. 1997;27:796–802
  2. Blum WF, Horn N, Kratzch J, Jorgensen JOL, Juul A, Teale D, et al. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul. 1993;3:100–104
  3. Booth BA, Boes M, Dake BL, Bar RS. Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3. Am J Physiol Endocrinol Metab. 1999;39:E450–E454
  4. Cheetham TD, Holly JMP, Baxter RC, Meadows K, Jones J, Taylor AM, et al. The effect of rhIGF-I administration on concentrations of ALS, IGFBP-3, IGF-I, IGF-II and proteolysis of IGFBP-3 in adolescents with IDDM. J Endocrinol. 1998;157:81–87
  5. Firth SM, Baxter RC. The role of glycosylation in the action of IGFBP-3. Progr Growth Factor Res. 1995;6:223–229
  6. Firth SM, Baxter RC. Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. J Endocrinol. 1999;160:379–387
  7. Firth SM, Ganeshprasad U, Baxter RC. Structural determinants of ligand and cell surface binding of insulin-like growth factor binding protein. J Biol Chem. 1998;273:2631–2638
  8. Goldstein IJ, Poretz RD. Isolation and chemical properties of lectins. In:  Liener IE,  Sharon N,  Goldstein IJ editor. The Lectins. Properties, Function and Applications in Biology and Medicine. Orlando: Academic Press; 1986;p. 33–247
  9. Hazel SJ, Sandberg Nordqvist AC, Hall K, Nilsson M, Schalling M. Differential expression of IGF-I and IGF- binding protein-1 and -2 in periportal and perivenous zones of rat liver. J Endocrinol. 1998;157:285–294
  10. Holt RIG, Crossey PA, Jones JS, Baker AJ, Portmann B, Miell JP. Hepatic growth hormone receptor, insulin-like growth factor I and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease. Hepatology. 1997;26:1600–1606
  11. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor-binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 1986;154:138–143
  12. Hussain MD, Micetich RG, Shysh A, Suresr MR. Studies on the in vivo and in vitro binding characteristics of breadfruit (Artocarpus altilis) lectin. Biochem Arch. 1990;6:159–168
  13. Inoue T, Yamauchi M, Toda G, Ohkawa K. Microheterogeneity with concanavalin A affinity of serum transferrin in patients with alcoholic liver disease. Alcohol Clin Exp Res. 1996;20:363A–365A
  14. Khosla S, Hassoun AAK, Baker BK, Liu F, Zein NN, Whyte MP, et al. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. J Clin Invest. 1998;101:2165–2173
  15. Kratzsch J, Blum WF, Schenker E, Keller E. Regulation of growth hormone (GH), insulin-like growth factor (IGF) I, IGF-binding proteins-1, -2, -3 and GH-binding protein during progression of liver cirrhosis. Exp Clin Endocrinol. 1995;103:285–291
  16. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med. 1993;204:4–29
  17. Nikolić JA, Nedić O, Masnikosa R. Determination of insulin-like growth factor-II in human serum. J Serb Chem Soc. 1998;63:805–815
  18. Nikolić JA, Nedić O, Gavrović M, Stojanović D, Živković B. Different serum insulin-like growth factor-I (IGF-I) binding characteristics accompany reduced growth associated with low thyroid hormone and/or low total IGF-I status in young pigs. Acta Vet. 1998;48:3–18
  19. Nikolić, J. A., Nedić, O., & Masnikosa, R. Peripheral serum of insulin-like growth factors (IGF-I and IG-II) decrease with age in healthy adults. Iugosl Physiol Pharmacol Acta, 35
  20. Nikolić JA, Ratković M, Nedić O. Determination of insulin-like growth factor-I by radioimmunoassay. J Serb Chem Soc. 1996;61:1149–1157
  21. Nikolić JA, Todorović V, Božić M, Tošić L, Bulajić M, Alempijević T, et al. Serum insulin-like factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosis. Clin Chim Acta. 2000;294:169–177
  22. Scharf JG, Ramadori G, Hartmann H. Contribution of Kupffer cells to the biosynthesis of the insulin-like growth factor system in rat liver. In:  Wisse E,  Knook DL,  Balabaud C editor. Cells of the Hepatic Sinusoid. Vol. 6:Leiden: Kupffer Cell Foundation; 1997;p. 363–365
  23. Scharf JG, Schmitz F, Frystyk J, Skjaerbaek C, Moesus H, Blum WF, et al. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol. 1996;25:689–699
  24. Shmueli E, Miell JP, Stewart M, Alberti KGMM, Record CO. High insulin-like growth factor binding protein-1 levels in cirrhosis. Link with insulin resistance. Hepatology. 1996;24:127–133
  25. Stewart CEH, Rotwein P. Growth, differentiation and survival. Multiple physiological functions for insulin-like growth factors. Phys Rev. 1996;76:1005–1026
  26. Stibler H, Borg S. Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scand J Clin Lab Invest. 1991;51:43–51
  27. Yu H, Mistry J, Nicar MJ, Khosravi J, Diamandis A, van Doom J, et al. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6 and ALS) in blood circulation. J Clin Lab Anal. 1999;13:166–172

PII: S0741-8329(00)00090-2

Alcohol
Volume 21, Issue 3 , Pages 223-229 , July 2000

Article Tools

* Image Usage & Resolution